We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$1.26B
AUM Growth
-$866M
Cap. Flow
-$1,000M
Cap. Flow %
-79.26%
Top 10 Hldgs %
18.19%
Holding
127
New
3
Increased
7
Reduced
113
Closed
4

Sector Composition

Rank Sector Weight
1 Industrials 23.15%
2 Financials 14.74%
3 Technology 13.29%
4 Healthcare 12.72%
5 Consumer Discretionary 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBHC icon
1
National Bank Holdings
NBHC
$1.9B
$26.7M 2.12%
691,875
-511,381
-42% -$18.9M
EFOR
2
Everforth Inc
EFOR
$960M
$25.1M 1.99%
321,188
-390,223
-55% -$31.9M
EPAY
3
DELISTED
Bottomline Technologies Inc
EPAY
$24.6M 1.95%
492,945
-386,185
-44% -$17.2M
MMSI icon
4
Merit Medical Systems
MMSI
$4.82B
$24.1M 1.91%
470,123
-434,214
-48% -$21.5M
WWE
5
DELISTED
World Wrestling Entertainment
WWE
$23.5M 1.86%
322,264
-601,209
-65% -$30.4M
ALE
6
DELISTED
Allete
ALE
$21.9M 1.74%
283,560
-247,674
-47% -$18.5M
AER icon
7
AerCap
AER
$23.4B
$21.6M 1.72%
399,644
-282,141
-41% -$15.2M
EEFT icon
8
Euronet Worldwide
EEFT
$3.19B
$21M 1.67%
251,205
-180,489
-42% -$14.6M
QTS
9
DELISTED
QTS REALTY TRUST, INC.
QTS
$20.4M 1.62%
517,642
-419,428
-45% -$15.5M
QDEL icon
10
QuidelOrtho
QDEL
$1.13B
$20.4M 1.62%
306,479
-106,644
-26% -$6.44M
CRI icon
11
Carter's
CRI
$1.43B
$19.5M 1.54%
179,609
-107,650
-37% -$11.6M
DY icon
12
Dycom Industries
DY
$11.2B
$19.2M 1.52%
202,960
-165,537
-45% -$16.9M
CHE icon
13
Chemed
CHE
$7.16B
$18.9M 1.5%
58,620
-50,941
-46% -$15.9M
FLWS icon
14
1-800-Flowers.com
FLWS
$252M
$17.5M 1.39%
1,394,428
-1,469,751
-51% -$18.6M
EVHC
15
DELISTED
Envision Healthcare Holdings Inc
EVHC
$17M 1.35%
386,583
-230,206
-37% -$9.46M
GWR
16
DELISTED
Genesee & Wyoming Inc.
GWR
$16.2M 1.29%
199,436
-152,140
-43% -$11.5M
EFII
17
DELISTED
Electronics for Imaging
EFII
$16.1M 1.28%
494,040
-309,125
-38% -$9.83M
PAY
18
DELISTED
Verifone Systems Inc
PAY
$15.9M 1.26%
698,307
-461,725
-40% -$10.2M
CAMP
19
DELISTED
CalAmp Corp.
CAMP
$15.9M 1.26%
29,438
-22,123
-43% -$11.1M
MNRO icon
20
Monro
MNRO
$415M
$15.8M 1.26%
272,484
-211,770
-44% -$12M
TISI icon
21
Team
TISI
$80.6M
$15.8M 1.25%
68,299
-47,200
-41% -$9.08M
HLF icon
22
Herbalife
HLF
$1.3B
$15.7M 1.24%
291,480
-273,496
-48% -$14.4M
ITRI icon
23
Itron
ITRI
$4.48B
$15.6M 1.23%
258,991
-187,126
-42% -$11.9M
B
24
DELISTED
Barnes Group Inc.
B
$15.5M 1.23%
263,570
-235,483
-47% -$14M
OPB
25
DELISTED
Opus Bank Common Stock
OPB
$15.5M 1.23%
539,451
-351,550
-39% -$10.1M

Similar funds

Aristotle Capital Boston's Q2 2018 Portfolio in Review

As of Q2 2018, Aristotle Capital Boston held 127 positions worth $1.26B, down 41% from $2.13B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Aristotle Capital Boston withdrew a net $1,000M in Q2 2018, closing 4 positions and reducing 113 holdings. Its most notable exit was Microsemi Corp, an estimated $40.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 20% a quarter earlier, followed by Financials and Technology.

Against the trend, Aristotle Capital Boston opened a new position in U.S. Xpress Enterprises, Inc. Class A Common Stock worth $4.81M.

  • Aristotle Capital Boston's largest Q2 2018 buy was U.S. Xpress Enterprises, Inc. Class A Common Stock: 317,801 shares worth $4.81M.
  • Aristotle Capital Boston added most to ATN International in Q2 2018, an estimated $2.64M increase.
  • Aristotle Capital Boston's biggest Q2 2018 reduction was Everforth Inc, cutting an estimated $31.9M.
  • Aristotle Capital Boston fully exited Microsemi Corp in Q2 2018, selling an estimated $40.1M.
  • Aristotle Capital Boston's ten largest holdings make up 18% of its $1.26B portfolio in Q2 2018.
  • Aristotle Capital Boston opened 3 new positions and closed 4 in Q2 2018.
  • Aristotle Capital Boston's portfolio value fell 41% quarter-over-quarter to $1.26B.

Based on Aristotle Capital Boston's 13F filing for Q2 2018, filed 13 Aug 2018.